An international research team has unveiled a groundbreaking biomarker in urine for prostate cancer detection, surpassing the efficacy of the traditional PSA test. By harnessing digital tumor models and advanced AI technology, they have pinpointed specific proteins capable of detecting both the presence and severity of the disease with unprecedented accuracy.
